At the request of BD, today's call is being recorded and will be available for replay on BD's Investor Relations website, investors.bd.com or by phone at 1-800-839-2486 for domestic calls and area ...
The Alaris recall also represented a significant blemish on the company’s previously very clean execution record. The magnitude of the damage to the pump franchise is still not certain ...
In 2023, infusion pumps accounted for the largest share of the home infusion therapy market, with over 45% of total revenue contribution. These pumps are widely used to administer controlled doses ...
Three strikes and you’re out? Not for Supernus Pharmaceuticals and its Parkinson’s disease infusion pump. | The device is ...
Hosted on MSN12d
Supernus wins FDA approval for Parkinson’s pump on fourth trySupernus Pharmaceuticals has won US approval for its wearable pump Onapgo (apomorphine hydrochloride) to treat symptoms of ...
In 2023, infusion pumps accounted for the largest share of the home infusion therapy market, with over 45% of total revenue contribution. These pumps are widely used to administer controlled doses of ...
Not surprising that medical devices such as infusion pumps, infusion monitors, or drip counters today are not only perceived as a tool for a routine service delivery. With the appearance of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback